Company Overview and News
E-commerce has made a significant impact in various industries including retail. With the growing appetite for convenient online shopping, a number of brick-and-mortar stores have been disrupted — with some even being forced out of business.
CAPITAL raised at the stock market reached a record P150 billion in the first half, as companies braved the local market amid prevailing volatility.
IRC PSKXF CHIB SUAFF RBLAY BSC DD CKGOY RLC PHSXY PSE FNI BCDTY
ROBINSONS LAND Corp. (RLC) is opening up one of its residential developments in the Bay Area to home-sharing online apps, seeking to capture the rising tourist market in the area.
ROBINSONS Land Corp. (RLC) is planning to develop a dormitory and shared office spaces in the future, seeking to cater to those who cannot afford to buy their own properties.
JG SUMMIT Holdings, Inc. is hiking its capital spending for 2018 as it aims to grow its petrochemical, airline, property, food and beverage, and banking businesses amid higher oil prices in the world market and the further depreciation of the peso.
JGSMY JGS RBNTF CEBUY UVRBY RBLAY CEBUF RLC RRETY URC CEB JGSHF UVRBF RRHI
ROXAS and Company, Inc. (RCI) expects its business ventures to stabilize in 2018, banking on its property projects and coconut processing plant to drive growth in the coming years.
RCI RLC RBLAY
Gokongwei-led conglomerate JG Summit saw a 35.8-percent year-on-year drop in first quarter net profit to P4.82 billion on slower earnings from the petrochemical and food businesses alongside some foreign exchange losses.
MER CEBUF RLC URC CEBUY UVRBY RBLAY CEB UVRBF
STOCKS are seen to rise in the week ahead as investors look for bargains amid the shortened trading week.
SVTMF SMCP1 SM RBLAY SMGBF SMIVY SMC PHSXY PSE SPHXF SPHZF MSCI AYAAF PSKXF AYAAY SMGBY SMPH SMC2B SMC2A SMC2D RLC SMC2C SMC2F SPHXY SMC2E ALI
2018-07-17 - Asif
History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...
2018-07-17 - Asif
Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...
2018-07-16 - Asif
General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...
Silicon Investor Message Boards
This table lists all message boards related to PSE:RLC / Robinsons Land Corporation on message board site Silicon Investor.
|Brillian (BRLC) - a Maker of LCoS for HDTV||RLCO: Realco, Inc.|